JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F–positive essential thrombocythemia

作者: Juan Li , Dominik Spensberger , Jong Sook Ahn , Shubha Anand , Philip A. Beer

DOI: 10.1182/BLOOD-2009-12-259747

关键词:

摘要: The JAK2 V617F mutation is found in most patients with a myeloproliferative neoplasm and sufficient to produce phenotype murine retroviral transplantation or transgenic models. However, several lines of evidence suggest that disease influenced by the level mutant signaling, we have therefore generated conditional knock-in mouse which human expressed under control Jak2 locus. Human transcripts are at similar levels, mice develop modest increases hemoglobin platelet levels reminiscent V617F–positive essential thrombocythemia. transplantable accompanied increased terminal erythroid megakaryocyte differentiation together numbers clonogenic progenitors, including erythropoietin-independent colonies. Unexpectedly, JAK2V617F reduced lineage−Sca-1+c-Kit+ cells, exhibit DNA damage, apoptosis, cell cycling. Moreover, competitive bone marrow studies demonstrated impaired hematopoietic stem function mice. These results chronicity neoplasms may reflect balance between accumulation additional mutations.

参考文章(45)
PJ Fialkow, GB Faguet, RJ Jacobson, K Vaidya, S Murphy, Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell Blood. ,vol. 58, pp. 916- 919 ,(1981) , 10.1182/BLOOD.V58.5.916.916
Takeshi Sato, Taira Maekawa, Sumiko Watanabe, Kohichiro Tsuji, Tatsutoshi Nakahata, Erythroid progenitors differentiate and mature in response to endogenous erythropoietin Journal of Clinical Investigation. ,vol. 106, pp. 263- 270 ,(2000) , 10.1172/JCI9361
E Antonioli, P Guglielmelli, A Pancrazzi, C Bogani, M Verrucci, V Ponziani, G Longo, A Bosi, A M Vannucchi, Clinical implications of the JAK2 V617F mutation in essential thrombocythemia Leukemia. ,vol. 19, pp. 1847- 1849 ,(2005) , 10.1038/SJ.LEU.2403902
Robert Kralovics, Francesco Passamonti, Andreas S. Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R. Passweg, Andre Tichelli, Mario Cazzola, Radek C. Skoda, A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders The New England Journal of Medicine. ,vol. 352, pp. 1779- 1790 ,(2005) , 10.1056/NEJMOA051113
Alexandra P. Wolanskyj, Terra L. Lasho, Susan M. Schwager, Rebecca F. McClure, Martha Wadleigh, Stephanie J. Lee, D. Gary Gilliland, Ayalew Tefferi, JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance British Journal of Haematology. ,vol. 131, pp. 208- 213 ,(2005) , 10.1111/J.1365-2141.2005.05764.X
Kristien Van Pelt, Friedel Nollet, Dominik Selleslag, Laurent Knoops, Stefan N. Constantinescu, Arnold Criel, Johan Billiet, The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation. Blood. ,vol. 112, pp. 921- 922 ,(2008) , 10.1182/BLOOD-2008-04-154708
Luigi A. Warren, Derrick J. Rossi, Stem cells and aging in the hematopoietic system Mechanisms of Ageing and Development. ,vol. 130, pp. 46- 53 ,(2009) , 10.1016/J.MAD.2008.03.010
Catherine Lacout, Didier F. Pisani, Micheline Tulliez, Françoise Moreau Gachelin, William Vainchenker, Jean-Luc Villeval, JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis Blood. ,vol. 108, pp. 1652- 1660 ,(2006) , 10.1182/BLOOD-2006-02-002030
P. J. Fialkow, S. M. Gartler, A. Yoshida, Clonal origin of chronic myelocytic leukemia in man Proceedings of the National Academy of Sciences of the United States of America. ,vol. 58, pp. 1468- 1471 ,(1967) , 10.1073/PNAS.58.4.1468
K Shide, H K Shimoda, T Kumano, K Karube, T Kameda, K Takenaka, S Oku, H Abe, K S Katayose, Y Kubuki, K Kusumoto, S Hasuike, Y Tahara, K Nagata, T Matsuda, K Ohshima, M Harada, K Shimoda, Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F Leukemia. ,vol. 22, pp. 87- 95 ,(2008) , 10.1038/SJ.LEU.2405043